A blood test that may predict if people with relapsed MM are going to respond well to CAR-T immunotherapy – Weill Cornell Medicine

Weill Cornell Medicine shared on X:

“A blood test that measures the number of lymphocytes may predict if people with relapsed multiple myeloma are going to respond well to CAR-T immunotherapy, according to new multi-institutional study led by Weill Department of Medicine.

Full story here.”